Ebit Изменить Дата
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amarin USD -2.26M 564K 2025-12
Amgen USD 4.68B 65M 2026-09
Baxter International USD 314M 38M 2026-09
Cara Therapeutics USD -7.05M 1.11M 2026-03
Cytokinetics USD -167.09M 12.08M 2026-09
DBV Technologies USD -64.8M 16.9M 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Halozyme Therapeutics USD -60.68M 3.04M 2026-09
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -130M 27.71M 2026-09
MannKind USD -59.44M 8.79M 2026-09
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Pfizer USD 4.85B 5.03B 2026-09
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
United Therapeutics USD 241.3M 134.3M 2026-09
Vanda Pharmaceuticals USD -10.28M 721K 2024-12